Compliance Strategy for Small to Midsized Companies

February 22, 2013

 

Published for Pharmaceutical Compliance Monitor

On Feb. 20, 2013, Jim Hoover’s article, “Compliance Strategy for Small to Midsized Companies,” published in the online version of Pharmaceutical Compliance Monitor. In the article, Jim discusses the basic steps that small to mid-sized pharmaceutical companies should take when conducting an internal investigation. He instructs  companies to carefully consider the scope and limits of the investigation, who should conduct the investigation, how to protect the relevant privileges, and the possible outcomes of the investigation, prior to conducting the investigation. By fully considering these factors, Jim suggests that companies will be in a better position to correct any problems identified and determine whether or not self-disclosure is warranted. For the full article, please click here.  





Legal Disclaimer:
No representation is made that the quality of services to be performed is greater than the quality of legal services performed by other lawyers.

Featured Attorneys

send article

TESTIMONIALS

  • “Excellent, with a strong reputation. He is very focused and enjoyable to work with.”

    -Chambers 2012

  • "Burr & Forman is the best firm we have had work for us. The lawyers are knowledgeable, responsive, and have a depth of expertise in all areas. We have a high level of confidence in their representation of our company."

    -Best Lawyers 2012

  • "Erich is great to work with.  He has a responsiveness that is second to none.  He and his team are always focused on obtaining the best outcome for their clients in a timely and cost efficient manner.  He is experienced, hard working, client minded, professional, and just an all around great attorney."

    -Anonymous

  • “He is very knowledgeable on asbestos, like a doctor when it comes to knowing the medical aspects of it…"

    -Chambers 2012

  • "...He is very good.”

    -Chambers 2012